Fosun earlier obtained the licence from Mainz-based BioNTech to exclusively develop and commercialise its mRNA Covid-19 vaccine products in China.
Fosun earlier obtained the licence from Mainz-based BioNTech to exclusively develop and commercialise its mRNA Covid-19 vaccine products in China.
0 Comments